QUINTA MANENJU: Open Payments
NPI 1629323464 · BOWIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$182 in 7 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $42 · 2025 $182
Food & beverage: $182
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $103 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Neurocrine BioSciences, Inc. | 1 | $30 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: FANAPT, COBENFY, INGREZZA, UZEDY.
Industry payments across MD — which companies pay providers there.
